180 Life Sciences
Jason Assad is an accomplished communications and corporate executive with extensive experience in various industries, including finance, biotechnology, and technology. Since 2000, Assad has served as President of C&H Capital Inc., a company focused on seed financing and strategic advisory services. Currently, Assad holds multiple positions such as Director of Corporate Communications at TeraWulf and Communications Strategist for Coya Therapeutics and Gain Therapeutics. Additionally, Assad has held roles at Crown Electrokinetics, Hoth Therapeutics, Unrivaled Brands, and Amergent Hospitality Group, demonstrating a strong background in investor relations and corporate communication. Assad is also an advisor and board member at Agrisel USA, Inc. and serves as President of LR Advisors LLC. Assad earned a Bachelor's Degree in Public Relations from The University of Georgia between 1989 and 1993.
This person is not in any teams
This person is not in any offices
180 Life Sciences
180 Life Sciences Corp. is a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University.